Phage therapy in allergic disorders?

Experimental Biology and Medicine

Volumn 243, Issue 6, 2018, Pages 534-537

  Górski, Andrzej ^a,b   Jończyk Matysiak, Ewa ^a   Łusiak Szelachowska, Marzanna ^a   Międzybrodzki, Ryszard ^a,b   Weber Dąbrowska, Beata ^a   Borysowski, Jan ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Allergy; immunomodulation; inflammation; phage

Indexed keywords

C REACTIVE PROTEIN; CD5 ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 10; REACTIVE OXYGEN METABOLITE; STEROID; TOLL LIKE RECEPTOR 4; IMMUNOLOGIC FACTOR;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BACTERIOPHAGE; DEGRANULATION; EOSINOPHILIA; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; LEUKOCYTOSIS; MAST CELL; MUCUS SECRETION; NETHERTON DISEASE; PHAGE THERAPY; UPREGULATION; ANIMAL; DRUG DEVELOPMENT; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOTHERAPY; PRECLINICAL STUDY; PROCEDURES; TRENDS;

ANIMALS; BACTERIOPHAGES; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; PHAGE THERAPY;

EID: 85044342766     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370218755658     Document Type: Article

References (41)

1. Gamazo C, D’Amelio C, Gastaminza G, Ferrer M, Irache JM., Adjuvants for allergy immunotherapeutics. Hum Vaccin Immunother 2017;13:2416–27
2. Górski A, Międzybrodzki R, Weber-Dąbrowska B, Fortuna W, Letkiewicz S, Rogóż P, Jończyk-Matysiak E, Dąbrowska K, Majewska J, Borysowski J., Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front Microbiol 2016;7:1515
3. Łusiak-Szelachowska M, Weber-Dąbrowska B, Jończyk-Matysiak E, Wojciechowska R, Górski A., Bacteriophages in the gastrointestinal tract and their implications. Gut Pathog 2017;9:44
4. Górski A, Weber-Dąbrowska B., The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 2005;62:511–9
5. Górski A, Ważna E, Weber-Dąbrowska B, Dąbrowska K, Świtała JK, Międzybrodzki R., Bacteriophage translocation. FEMS Immunol Med Microbiol 2006;46:313–9
6. Międzybrodzki R, Fortuna W, Weber-Dąbrowska B, Górski A., A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses. Clin Exp Med 2009;9:303–12
7. Górski A, Dąbrowska K, Międzybrodzki R, Weber-Dąbrowska B, Łusiak-Szelachowska M, Jończyk-Matysiak E, Borysowski J., Phages and immunomodulation. Future Microbiol 2017;12:905–14
8. Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J., Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci USA 2013;110:10771–6
9. Barr JJ., A bacteriophages journey through the human body. Immunol Rev 2017;279:106–22
10. Van Belleghem JD, Clement F, Merabishvili M, Lavigne R, Vaneechoutte M., Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci Rep 2017;7:8004
11. Sun Y, Feng B., Inflammation response of phage-based films on titanium surface in vitro. Faseb J 2017;31:657
12. Borysowski J, Międzybrodzki R, Wierzbicki P, Kłosowska D, Korczak-Kowalska G, Weber-Dąbrowska B, Górski A., A3R phage and Staphylococcus aureus lysate do not induce neutrophil degranulation. Viruses 2017;9:E36
13. Międzybrodzki R, Borysowski J, Kłak M, Jończyk-Matysiak E, Obmińska-Mrukowicz B, Suszko A, Pawłowska A, Bubak B, Weber-Dąbrowska B, Górski A., In vivo studies on influence of bacteriophage preparations on the autoimmune inflammatory process. Biomed Res Int 2017; 2017:ID 3612015
14. Wang SB, Deng YQ, Ren J, Xiao BK, Liu Z, Tao ZZ., Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model. BMC Immunol 2014;15:9
15. Bundoc VG, Keane-Myers A., IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp Eye Res 2007;85:575–9
16. Kim HS, Kim AR, Kim DK, Kim HW, Park YH, Jang GH, Kim B, Park YM, You JS, Kim HS, Beaven MA, Kim YM, Choi WS., Interleukin-10-producing CD5+B cells inhibit mast cells during immunoglobulin E-mediated allergic responses. Sci Signal 2015;8:ra28
17. Matsuda M, Doi K, Tsutsumi T, Fujii S, Kishima M, Nishimura K., Regulation of allergic airway inflammation by adoptive transfer of CD4+T cells preferentially producing IL-10. Eur J Pharmacol 2017;812:38–47
18. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K., Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98–106
19. Wang CC, Fu CL, Yang YH, Lo YC, Wang YH, Chuang YH, Chang DM, Chiang BL., Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther 2006;13:1414–21
20. Gurusamy M, Nasseri S, Lee H, Jung B, Lee D, Khang G, Abraham WM, Doods H, Wu D., Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice. Pharmacol Res 2016;104:132–9
21. Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono S, Dana MR., Prevention of allergic eye disease by treatment with IL-1 receptor antagonist. Invest Ophthalmol Vis Sci 1999;40:3041–6
22. Bowler RP, Crapo JD., Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002;110:349–56
23. Qui J, Li Y, Zhong W, Gao P, Hu C., Recent developments in the role of reactive oxygen species in allergic asthma. J Thorac Dis 2017;9:E32–43
24. Borysowski J, Wierzbicki P, Kłosowska D, Korczak-Kowalska G, Weber-Dąbrowska B, Górski A., The effects of T4 and A3/R phage preparations on whole-blood monocyte and neutrophil respiratory burst. Viral Immunol 2010;23:541–4
25. Przerwa A, Zimecki M, Świtała-Jeleń K, Dąbrowska K, Krawczyk E, Łuczak M, Weber-Dabrowska B, Syper D, Międzybrodzki R, Górski A., Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol 2006;195:143–50
26. Międzybrodzki R, Świtała-Jeleń K, Fortuna W, Weber-Dąbrowska B, Przerwa A, Łusiak-Szelachowska M, Dąbrowska K, Kurzepa A, Boratynski J, Syper D, Pozniak G, Lugowski C, Gorski A., Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. Virus Res 2008;131:233–42
27. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009;15:410–6
28. Riiser A., The human microbiome, asthma, and allergy. Allergy Asthma Clin Immunol 2015;11:35
29. Björksten B, Naaber P, Sepp E, Mikelsaar M., The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342–6
30. Baker BS., The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144:1–9
31. Międzybrodzki R, Borysowski J, Weber-Dąbrowska B, Fortuna W, Letkiewicz S, Szufnarowski K, Pawełczyk Z, Rogóż P, Kłak M, Wojtasik E, Górski A., Clinical aspects of phage therapy. Adv Virus Res 2012;83:73–121
32. Górski A, Kniotek M, Perkowska-Ptasińska A, Mróz A, Przerwa A, Gorczyca W, Dabrowska K, Weber-Dabrowska B, Nowaczyk M., Bacteriophages and transplantation tolerance. Transplant Proc 2006;38:331–3
33. Miernikiewicz P, Kłopot A, Soluch R, Szkuta P, Kęska W, Hodyra-Stefaniak K, Konopka A, Nowak M, Lecion D, Kaźmierczak Z, Majewska J, Harhala M, Górski A, Dabrowska K., T4 phage tail adhesin Gp12 counteracts LPS-induced inflammation in vivo. Front Microbiol 2016;7:1112
34. Górski A, Borysowski J, Międzybrodzki R, Weber-Dąbrowska B., Bacteriophages in medicine. In: McGrath S, van Sinderen D (eds) Bacteriophage: genetics and molecular biology. Poole, UK: Caister Academic Press, 2007, pp.125–158.
35. Sheerin KA, Buckley RH., Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol 1991;87:803–11
36. Lack G, Ochs HD, Gelfand EW., Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia. J Pediatr 1996;129:898–903
37. Sakandelidze VM., The combined use of specific phages and antibiotics in different infectious allergoses. Vrach Delo 1991;3:60–3
38. Ligonenko OV, Borysenko MM, Digtyar II, Ivashchenko DM, Zubakha AB, Chorna IO, Shumeyko IA, Storozhenko OV, Gorb LI, Ligonenko OO., Application of bacteriophages in complex of treatment of a shot-gun wounds of soft tissues in the patients, suffering multiple allergy for antibiotics. Klin Khir 2015;10:65–6
39. Baker AG., Treatment of chronic bronchial asthma; aerosol of Staphylococcus bacteriophage lysate as an adjunct to systemic hyposensitization. Am Pract Dig Treat 1958;9:591–8
40. Baker AG., Staphylococcus bacteriophage lysate: topical and parenteral use in allergic patients. Pa Med J 1963;66:25–8
41. Zhvania P, Hoyle NS, Nadareishvili L, Nizharadze D, Kutateladze M., Phage therapy in a 16-year-old boy with Netherton syndrome. Front Med 2017;4:94